Business Context and Reporting Period
This Form 8-K filing by Calyxt, Inc. (trading symbol: CLXT) was submitted on April 24, 2023. The report details a material corporate action involving a one-for-ten reverse stock split of the Company's common stock. The filing was made to comply with Section 13 or 15(d) of the Securities Exchange Act of 1934.
Key Financial Metrics
This filing is a current report regarding a capital structure change and does not contain financial performance data. The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
- Reverse Stock Split: A one-for-ten reverse stock split was effected via a Certificate of Amendment filed on April 24, 2023, effective at 4:30 p.m. Eastern time.
- Trading Adjustments: Common stock began trading on a split-adjusted basis on April 25, 2023, under the symbol "CLXT" with a new CUSIP number (13173L206).
- Authorized Shares: The split has no effect on the number of authorized shares or the par value ($0.0001) of the common stock.
- Registration Statements: The number of shares registered on Forms S-3, S-4, and S-8 were proportionately reduced.
- Equity Plans: Anti-dilution adjustments were made to the 2017 Omnibus Incentive Plan, 2014 Equity Incentive Plan, and 2021 Employee Inducement Incentive Plan, including adjustments to outstanding awards.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future performance, or specific risk factors beyond the procedural details of the stock split. The primary event is the administrative adjustment of the Company's capital structure.
Investor Verification Checklist
- Verify the new CUSIP number (13173L206) for trading purposes.
- Confirm the split-adjusted share count in brokerage accounts following the April 25, 2023 trading date.
- Review the impact of the anti-dilution adjustments on outstanding equity awards under the 2017, 2014, and 2021 plans.
- Check the updated number of shares available for issuance under the Company's active registration statements (Forms S-3, S-4, and S-8).